Sm Capital

S.M Capital is the offspring of MJ Shah Group. MJ Shah Group began its operations in the pharmaceutical industry back in 1959 with Biochem Pharmaceutical Industries.It was one of the first companies to bring the antibiotic Ampicillin to India. The company was also credited with treating the Indian Army during the 1965 war. Biochem also revolutionised the way cancer patients were treated in India by introducing the first anti-cancer Mitomycin-C injections.The group strategically divested the pharmaceuticals business in order to begin long-term investments in leading real estate funds. MJ Shah Group has built and run its businesses with a sharp focus on its customers. “Creating Value” is one of the core beliefs at MJ Shah Group and we at SM Capital aim to carry it forward by keeping this core belief at the centre of our investment strategies. By inheriting the trust of our associates and as an active investment team for the family’s financial activities, we are now venturing into investment management. Investing with High Conviction Across its investment platform, S M Capital manages concentrated and high-conviction portfolios. Bottom-up fundamental research and long-term value creation are central to the investment process